Arcturus Therapeutics Announces Strategic Collaboration with Thermo Fisher Scientific to Advance ARCT-032 for Cystic Fibrosis

Arcturus Therapeutics Holdings Inc. ("Arcturus", Nasdaq: ARCT), a messenger RNA medicines company focused on the development ...
Clinical Trials Arena on MSN

Thermo Fisher, Arcturus partner on Phase III ARCT-032 cystic fibrosis trial

Thermo Fisher will provide integrated manufacturing, clinical research and commercial readiness services.

Arcturus could halve the grid’s electrical losses using its nano-infused copper

Stealthy startup Arcturus uses lasers to infuse carbon nanomaterials into copper, dramatically improving its ability to ...

Arcturus Emerges from Stealth with $8M in Seed Funding to ‘Rewire the World’ with Metals Infused with Carbon Nanomaterials

Arcturus, an advanced materials company that infuses carbon nanomaterials into metals to unlock step-change improvements in electrical, thermal, and mechanical performance, today emerged from stealth ...
NewsBytes

Arcturus's laser method could cut grid losses up to 50%

Arcturus has developed nano-infused copper that reduces energy loss by half, unlocking up to 10% more electricity during peak ...